![]() |
![]() |
Metyrapone testDefinitionThe metyrapone test measures the ability of the pituitary gland to release adrenocorticotropic hormone (ACTH) in response to decreased blood cortisol levels. How the Test is PerformedThere are two different types of metyrapone tests. The first is an overnight test. A single dose of metyrapone is given at 11 p.m. and blood is drawn at 8 a.m. for measurement of serum cortisol, ACTH, and another hormone called 11-deoxycortisol. In the second form of the test, metyrapone is given 6 times a day for 24 hours and then a 24-hour urine sample is collected for measurement of 17-OHCS (a metabolic product of cortisol). Blood samples for serum cortisol, ACTH, and 11-deoxycortisol may also be drawn. How to Prepare for the TestThe health care provider may tell you to temporarily stop taking any drugs that may affect test results. This may include rifampin, phenobarbital, or phenytoin. The drugs may have to be stopped for several weeks before to the test. Other drugs that can affect metyrapone test results include chlorpromazine, corticosteroids, birth control pills, and other estrogen-containing medications. How the Test Will FeelWhen the needle is inserted to draw blood, some people feel moderate pain, while others feel only a prick or stinging sensation. Afterward, there may be some throbbing. Why the Test is PerformedThe test is done to determine whether the pituitary gland is working properly. Normal ResultsNormal values for the blood tests:
A normal value for the 24-hour urine test shows that the baseline excretion of urinary 17-OHCS more than doubled. Normal value ranges may vary slightly among different laboratories. Talk to your doctor about the meaning of your specific test results. What Abnormal Results MeanAbnormal results may be due to Cushing syndrome or adrenal insufficiency. The test may help distinguish between the different types of Cushing syndrome. Risks
ConsiderationsAbnormal thyroid function can affect this test. ReferencesNieman LK. Dynamic evaluation of adrenal hypofunction. J Endocrinol Invest. 2003;26 & Suppl):74-82.
Review Date:
10/24/2007 Reviewed By: Robert Hurd, MD, Professor of Endocrinology, Department of Biology, Xavier University, Cincinnati, OH, and physician in the Primary Care Clinic, Cincinnati Veterans Administration Medical Center, Cincinnati, Ohio. Review provided by VeriMed Healthcare Network. The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-
A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited. |